Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Amnesteem Cannot Claim “Esteem,” FDA Tells Mylan In Letter On Acne Drug

Executive Summary

FDA is citing Mylan for claims on Amesteem's website that the acne product can address problems with low self-esteem
Advertisement

Related Content

Mylan Gets First-Ever GMP Warning Letter
Websites Must Be Submitted To FDA Like Other Ads, Agency Reminds Industry
Websites Must Be Submitted To FDA Like Other Ads, Agency Reminds Industry
Roche Accutane Exhibit Hall Response On Psychosis Risk Draws FDA Letter
Celebrex TV Ads Modified After FDA Says Pharmacia Overstated Efficacy
Celebrex TV Ads Modified After FDA Says Pharmacia Overstated Efficacy
Ligand Targretin
Advertisement
UsernamePublicRestriction

Register

PS042025

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel